Description
Lipaglyn Tablet is a prescription medication used to manage type 2 diabetes mellitus. Its active ingredient, Saroglitazar, is a novel dual PPAR agonist that works by activating peroxisome proliferator-activated receptors (PPARs) alpha and gamma. This dual action helps to improve insulin sensitivity, reduce inflammation, and lower lipid levels. By activating PPAR alpha, Saroglitazar helps in the metabolism of fats, leading to a reduction in triglycerides and an increase in HDL cholesterol. Activation of PPAR gamma enhances insulin sensitivity in peripheral tissues, thereby improving glucose uptake and utilization. This comprehensive approach makes Lipaglyn Tablet effective in controlling blood sugar levels and improving the overall lipid profile in patients with type 2 diabetes. It is typically prescribed as an adjunct to diet and exercise. Common side effects may include gastrointestinal disturbances, headache, and dizziness. It is important to take Lipaglyn Tablet exactly as prescribed by your healthcare provider. Store the tablets at room temperature, away from moisture and heat.
